| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $236.2M | +47.5% |
| Cost of Revenue | $39.5M | -37.5% |
| R&D Expense | $62.4M | +65.6% |
| SG&A Expense | $107.5M | +0.9% |
| Operating Income | $23.5M | +146.6% |
| Pre-tax Income | -$3.7M | +94.6% |
| Income Tax | $1.6M | — |
| Net Income | -$5.3M | +92.3% |
| EPS (Basic) | -$0.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $184.8M | +256.4% |
| Accounts Receivable | $47.0M | +36.8% |
| Inventory | $15.6M | -3.9% |
| Current Assets | $253.0M | +122.2% |
| Total Assets | $376.6M | +70.6% |
| Current Liabilities | $162.9M | +101.4% |
| Long-term Debt | $48.3M | +24.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $68.0M | +267.2% |
| Capital Expenditures | $291K | +781.8% |
| Investing Cash Flow | -$7.9M | — |
| Financing Cash Flow | $72.9M | +46.8% |
| Free Cash Flow | $67.7M | +266.4% |
| +93.9% |
| EPS (Diluted) | -$0.02 | +93.9% |
| Total Liabilities |
| $344.0M |
| +27.5% |
| Stockholders' Equity | $32.6M | +166.3% |